Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 58 Breast Neoplasms 25 Neoplasms 5 Neoplasm Metastasis 3 Leiomyoma 3 Polycystic Ovary Syndrome 2 Neoplasms by Site 2 Endometrial Neoplasms 2 Cardiovascular Diseases 2 Breast Diseases 2 Stage II Prostate Adenocarcinoma 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Salivary Gland Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatectomy 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Pelvic Pain 1 Ovarian Neoplasms 1 Osteoporosis 1 Oligometastatic Prostate Carcinoma 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Kallmann Syndrome 1 Inflammatory Breast Neoplasms 1

Interventions

Fulvestrant 19 Letrozole 8 Anastrozole 6 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Injections 4 Goserelin 4 Docetaxel 4 pyrotinib 3 exemestane 3 trastuzumab deruxtecan 2 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 abemaciclib 2 Vinorelbine 2 Trastuzumab 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × Gonadotropin-Releasing Hormone × Clear all

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡